Course Description:
The design and establishment of the laboratory facility, test methods and materials handling are impacted by stringent guidelines defined by regulatory agencies including the Food and Drug Administration (FDA), International Conference on Harmonization (ICH) and represented as Good Laboratory Practice (GLP) regulations delineated in 21 CFR Part 58. An additional component of a preclinical development program is the necessity of periodic internal and external audits of the facilities to ascertain the enforcement and consequent adherence of quality policies. The management systems that are encompassed by regulatory scrutiny include but are not limited to GLP practices and technique, bio-safety handling practices, standard operating procedural compliance, methods validation, organizational structure, training, proficiency assessment and qualifications of personnel, reagent certification, document control involving the recording, reporting and archiving of information, and laboratory management systems.
This interactive course will provide comprehensive guidelines and strategies for conducting and managing a preclinical development program for biologic candidates eventually leading to IND studies. The guidelines will be in accordance with current global regulatory (FDA, ICH) directives, and the management of these mandates will ensure successful audits for compliance, and submissions. Target areas for potential compliance infractions, resolution of audit findings, and pertinent case studies regarding the issuance of 483s and warning letters will be discussed.
The GLP compliance regulations discussed in this course will be applicable to biologics, pharmaceuticals and medical devices.
Topic Background:
The basic premise of Good Laboratory Practice (GLP) is to monitor universities, contract laboratories and biopharmaceutical companies that conduct animal and clinical studies to ensure the quality and authenticity of drug safety information. These GLP requirements were established by regulatory authorities in the 1970s following inspections of institutions that revealed appalling animal testing conditions and deceptive data reports submitted for FDA approval. Preclinical testing for the assessment of efficacy and safety of biologic therapeutics, and the performance of medical devices is an integral component of product development. A majority of preclinical studies are impacted by stringent GLP regulations if they are components of efficacy and safety informational packages seeking FDA approval for marketing permits. In addition, these studies are essential precursors for the identification of effective dosage levels, key pharmacokinetic efficacy and safety parameters, and specification limits prior to embarking on human clinical trials. The evaluations are performed in vitro systems and in vivo animal models following optimized, approved standard operating procedures. These protocols are specific for the physiochemical qualification and mechanism of action of the drug candidate.
Who will Benefit:
- Executive management
- R&D investigators
- Product development
- Pre-clinical and clinical
- Regulatory affairs
- QA/ QC
- Marketing
- Consultants
- Training
Course Outline:
Day 1 |
Day 2 |
Lunch
Break |
Lunch
Break
|
Meet Your Instructor
 |
Chitra Edwin Principal, Biotechnology Consulting Solutions LTD Chitra Edwin, Ph.D., RAC. has significant product development and management experience in start-ups, mid-sized and large biotechnology and diagnostic companies. She has managed projects from concept, R&D through manufacturing transfer, and has been a key member in the development of products for AIDS and cancer that have obtained FDA approval and are commercially available. She has successfully established and managed GLP and CLIA compliant laboratories, managed multidisciplinary project teams, executed technology transfers, and orchestrated collaborations between national and international professionals. Dr. Edwin obtained her Ph.D. in Medical Microbiology and Immunology from the University of Minnesota, followed by post-doctoral training in Infectious Diseases at the Harvard Medical School and the Dana Farber Cancer Institute. She has secured Regulatory Affairs board certification (RAC). She is a Review Board member of Opus Institutional Review Board (IRB). She was a co-founder and President of the Graduate Women in Science (Massachusetts chapter). Memberships have been held in Sigma Xi; Scientific Research Society, ASM, AAAS, RAPS, MIT Forum, GWIS, the Foreign Policy Leadership Council of Greater Cincinnati, BioOhio and Kindervelt. |
Register Now
Online using Credit card
|
Other Registration Option
- Download the Order Form
- Fill this form with attendee details & payment details
- Fax it to +1-650-362-2367, or
- Email it to [email protected]
Payment Mode
ComplianceOnline (MetricStream, Inc),
6201 America Center Drive Suite 240
San Jose, CA 95002
USA
Register / Pay by Wire Transfer
Please contact us at +1-888-717-2436 to get details of wire transfer option.Terms & Conditions to register for the Seminar/Conference/Event
Your Registration for the seminar is subject to following terms and conditions. If you need any clarification before registering for this seminar please call us @ +1-888-717-2436 or email us @ [email protected]
Payment:
Payment is required before 2 days of the date of the conference. We accept American Express, Visa and MasterCard. Make checks payable to MetricStream Inc. ( our parent company)
Cancellations and Substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 10 calendar days prior to the start date of the event will receive a refund — less a $200 administration fee. No cancellations will be accepted — nor refunds issued — within 10 calendar days from the start date of the event.
On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($200) will be transferred to any future ComplianceOnline event and a credit note will be issued.
Substitutions may be made at any time. No-shows will be charged the full amount.
We discourage onsite registrations, however if you wish to register onsite payment to happen through credit card immediately or check to be submitted onsite. Conference material will be given on the spot if it is available after distributing to other attendees. In case it is not available we will send the material after the conference is over.
In the event ComplianceOnline cancels the seminar, ComplianceOnline is not responsible for any airfare, hotel, other costs or losses incurred by registrants. Some topics and speakers may be subject to change without notice.
Attendance confirmation and Documents to carry to the seminar venue:
After we receive the payment from the registered attendee an electronic event pass will be sent to the email address associated with the registrant before 5 working days from the seminar date. Please bring the pass to the venue of the event.
Conference photograph / video:
By registering and attending ComplianceOnline conference you agree to have your photographs or videos taken at the conference venue and you do not have any objections to use these photos and videos by ComplianceOnline for marketing, archiving or any other conference related activities. You agree to release ComplianceOnline for any kind of claims arising out of copyright or privacy violations.
|
